Drugs in R&D View Homepage


Ontology type: schema:Periodical      Open Access: True


Journal Info

START YEAR

1999

PUBLISHER

Springer International Publishing

LANGUAGE

en

HOMEPAGE

https://link.springer.com/journal/40268

Recent publications latest 20 shown

  • 2021-11-26 Coenzyme Q10 in the Treatment of Heart Failure with Preserved Ejection Fraction: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
  • 2021-11-09 The Anti-inflammatory Effect of Dexmedetomidine Administration on Patients Undergoing Intestinal Surgery: A Randomized Study
  • 2021-11-09 Acknowledgement to Referees
  • 2021-11-06 Clinical and Preclinical Single-Dose Pharmacokinetics of VIR-2218, an RNAi Therapeutic Targeting HBV Infection
  • 2021-10-25 Pharmacokinetics of the Melanocortin Type 1 Receptor Agonist PL8177 After Subcutaneous Administration
  • 2021-10-23 Author’s Reply to Petersen: “Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS”
  • 2021-10-20 Comment on: “Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS”
  • 2021-10-15 Effects of Letermovir and/or Methylprednisolone Coadministration on Voriconazole Pharmacokinetics in Hematopoietic Stem Cell Transplantation: A Population Pharmacokinetic Study
  • 2021-10-09 Prediction of Belimumab Pharmacokinetics in Chinese Pediatric Patients with Systemic Lupus Erythematosus
  • 2021-09-25 Dissociated Responses in Patients with Metastatic Solid Tumors Treated with Immunotherapy
  • 2021-09-20 The Safety of Agalsidase Alfa Enzyme Replacement Therapy in Canadian Patients with Fabry Disease Following Implementation of a Bioreactor Process
  • 2021-08-25 Improvement of Intranasal Drug Delivery with Intravail® Alkylsaccharide Excipient as a Mucosal Absorption Enhancer Aiding in the Treatment of Conditions of the Central Nervous System
  • 2021-08-07 Apixaban Pharmacokinetics and Pharmacodynamics in Subjects with Mild or Moderate Hepatic Impairment
  • 2021-08-05 Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2
  • 2021-08-04 Safety and Systemic Exposure of Triamcinolone Acetonide Following Ultrasound-Guided Intra-Articular Injection of Triamcinolone Extended-Release or Standard Triamcinolone Acetonide in Patients with Shoulder Osteoarthritis: An Open-Label, Randomized Study
  • 2021-07-29 A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor
  • 2021-07-20 A Novel In Vitro Model for Determining the Optimum pH and Dose Volume of New Liquid Alginate for Infant Reflux Suppression
  • 2021-07-19 Predicting Inter-individual Variability During Lipid Resuscitation of Bupivacaine Cardiotoxicity in Rats: A Virtual Population Modeling Study
  • 2021-06-25 Long-Term Maintenance of Golimumab Effectiveness for Injection Spacing in Rheumatoid Arthritis Patients with Low Disease Activity Who Previously Received Other TNF Inhibitors: Minimum 2-year Data From an Observational Study
  • 2021-06-23 Safety and Pharmacokinetics of HTL0018318, a Novel M1 Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "1.3559999465942383", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "0.8730000257492065", 
            "type": "Rating"
          }
        ], 
        "description": "

    Drugs in R&D publishes original research and reviews from all phases of drug development and on clinical use of drugs following approval.

    \n\n

    The journal was re-launched in 2010 as the first Open Access journal from Adis, making all content from 2010 onwards freely available online. Pre-2010 content is not available as Open Access.

    \n\n

    Drugs in R&D offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

    \n\n

    Manuscripts submitted to the journal for publication will be subject to an article processing charge (APC) upon acceptance. Please click on the ‘Fees and funding’ link for details of the current APC and open access funding and support services. Adis Open Access enables you to make your journal article freely available to anyone, in exchange for payment of APC. This option allows you, the author, to retain the copyright of the article according to the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC) License, which does not permit commercial re-use of the article.

    \n", "editor": [ { "familyName": "van Rensburg", "givenName": "Anton", "type": "Person" } ], "id": "sg:journal.1020803", "inLanguage": [ "en" ], "isAccessibleForFree": true, "issn": [ "1174-5886", "1179-6901" ], "license": "Fully Open Access", "name": "Drugs in R&D", "productId": [ { "name": "dimensions_id", "type": "PropertyValue", "value": [ "20803" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "sn99-39864" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "100883647" ] }, { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "439979" ] }, { "name": "era_ids_id", "type": "PropertyValue", "value": [ "200390" ] } ], "publisher": { "name": "Springer International Publishing", "type": "Organization" }, "publisherImprint": "Adis", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1020803" ], "sdDataset": "journals", "sdDatePublished": "2021-12-01T20:17", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/journal/journal_0.jsonl", "startYear": "1999", "type": "Periodical", "url": "https://link.springer.com/journal/40268" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1020803'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1020803'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1020803'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1020803'


     

    This table displays all metadata directly associated to this object as RDF triples.

    60 TRIPLES      20 PREDICATES      27 URIs      23 LITERALS      10 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1020803 schema:contentRating N921ce6837c6b480aabfd5b0ac4378cb5
    2 Nffa80faa4067425da15d9286cd340575
    3 schema:description <p><em>Drugs in R&amp;D</em> publishes original research and reviews from all phases of drug development and on clinical use of drugs following approval.</p> <p>The journal was re-launched in 2010 as the first Open Access journal from Adis, making all content from 2010 onwards freely available online. Pre-2010 content is not available as Open Access.</p> <p><em>Drugs in R&amp;D</em> offers a range of additional features designed to increase the visibility, readership and educational value of the journal&rsquo;s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager&reg;, supported by a database of international experts. This database is shared with other Adis journals.</p> <p>Manuscripts submitted to the journal for publication will be subject to an article processing charge (APC) upon acceptance.&nbsp;Please click on the &lsquo;Fees and funding&rsquo; link for details of the current APC and open access funding and support services. Adis Open Access enables you to make your journal article freely available to anyone, in exchange for payment of APC. This option allows you, the author, to retain the copyright of the article according to the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC) License, which does not permit commercial re-use of the article.</p>
    4 schema:editor Nc3945c06ef104cf7ae3a2ce1a94890e3
    5 schema:inLanguage en
    6 schema:isAccessibleForFree true
    7 schema:issn 1174-5886
    8 1179-6901
    9 schema:license Fully Open Access
    10 schema:name Drugs in R&D
    11 schema:productId N52142724b9e1491bb79bbd0362a19de4
    12 N5ae9763c8d9f4caaaf5787f0748b9502
    13 N6000431a95f64692b15737034b8d0e96
    14 N8bee42b6acfd4b688d4bd0397cbaebd5
    15 Na99893ed01444c28af7a650686d1fbcb
    16 schema:publisher Nd09f283bab4847b6886556ba7a8c9dbb
    17 schema:publisherImprint Adis
    18 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1020803
    19 schema:sdDatePublished 2021-12-01T20:17
    20 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    21 schema:sdPublisher Nd908aebafc89488cad8e98be4dcd493b
    22 schema:startYear 1999
    23 schema:url https://link.springer.com/journal/40268
    24 sgo:license sg:explorer/license/
    25 sgo:sdDataset journals
    26 rdf:type schema:Periodical
    27 N52142724b9e1491bb79bbd0362a19de4 schema:name lccn_id
    28 schema:value sn99-39864
    29 rdf:type schema:PropertyValue
    30 N5ae9763c8d9f4caaaf5787f0748b9502 schema:name dimensions_id
    31 schema:value 20803
    32 rdf:type schema:PropertyValue
    33 N6000431a95f64692b15737034b8d0e96 schema:name nsd_ids_id
    34 schema:value 439979
    35 rdf:type schema:PropertyValue
    36 N8bee42b6acfd4b688d4bd0397cbaebd5 schema:name era_ids_id
    37 schema:value 200390
    38 rdf:type schema:PropertyValue
    39 N8e2b7a371f1d4ab786bb5c2645785eeb rdf:first sjr
    40 rdf:rest rdf:nil
    41 N921ce6837c6b480aabfd5b0ac4378cb5 schema:author Ndc6cbf2dbf254105b0100a2dc3ad8213
    42 schema:ratingValue 1.3559999465942383
    43 rdf:type schema:Rating
    44 Na99893ed01444c28af7a650686d1fbcb schema:name nlm_unique_id
    45 schema:value 100883647
    46 rdf:type schema:PropertyValue
    47 Nc3945c06ef104cf7ae3a2ce1a94890e3 rdf:first Nef3a5026f51d4c369e6006344f78089c
    48 rdf:rest rdf:nil
    49 Nd09f283bab4847b6886556ba7a8c9dbb schema:name Springer International Publishing
    50 rdf:type schema:Organization
    51 Nd908aebafc89488cad8e98be4dcd493b schema:name Springer Nature - SN SciGraph project
    52 rdf:type schema:Organization
    53 Ndc6cbf2dbf254105b0100a2dc3ad8213 rdf:first snip
    54 rdf:rest rdf:nil
    55 Nef3a5026f51d4c369e6006344f78089c schema:familyName van Rensburg
    56 schema:givenName Anton
    57 rdf:type schema:Person
    58 Nffa80faa4067425da15d9286cd340575 schema:author N8e2b7a371f1d4ab786bb5c2645785eeb
    59 schema:ratingValue 0.8730000257492065
    60 rdf:type schema:Rating
     




    Preview window. Press ESC to close (or click here)


    ...